SCHEMBL19909101

SCHEMBL19909101

N#Cc1cc(C#N)cc(-c2ccc3c(c2)c2ccccc2n3-c2cc(C#N)cc(-n3c4ccccc4c4cc(-c5cc(C#N)cc(C#N)c5)ccc43)c2-c2cc(-c3ccccc3)nc(-c3ccccc3)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MYC P01106 1/20 0.41
ALDH1A3 P47895 2/20 0.38
GABRG2 P18507 3/20 0.37
GABRB3 P28472 3/20 0.37
GABRA5 P31644 3/20 0.37
GABRA3 P34903 3/20 0.37
GABRA1 P14867 2/20 0.37
ABCG2 Q9UNQ0 2/20 0.36
ABCB1 P08183 1/20 0.36
PTGER4 P35408 1/20 0.34
KDM4E B2RXH2 2/20 0.33
ADORA2A P29274 2/20 0.33
SQOR Q9Y6N5 2/20 0.33
HPGD P15428 1/20 0.33
PPARG P37231 1/20 0.33
NCOA2 Q15596 1/20 0.33
NCOA1 Q15788 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NCOA3 Q9Y6Q9 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19909244 0.97 MYC (0.43) MYCALDH1A3GABRG2GABRB3GABRA5
SCHEMBL19909175 0.96 MYC (0.42) MYCALDH1A3GABRG2GABRB3GABRA5
SCHEMBL19909183 0.95 ALDH1A3 (0.45) MYCALDH1A3GABRG2GABRB3GABRA5
SCHEMBL19909502 0.94 MYC (0.46) MYCALDH1A3GABRG2GABRB3GABRA5
SCHEMBL19913300 0.93 ABCG2 (0.39) MYCALDH1A3GABRG2GABRB3GABRA5
SCHEMBL19909174 0.92 MYC (0.44) MYCALDH1A3GABRG2GABRB3GABRA5
SCHEMBL19913285 0.92 MYC (0.38) MYCALDH1A3GABRG2GABRB3GABRA5
SCHEMBL22563584 0.91 ABCG2 (0.38) MYCALDH1A3GABRG2GABRB3GABRA5
SCHEMBL22562260 0.90 ALDH1A3 (0.40) MYCALDH1A3GABRG2GABRB3GABRA5
SCHEMBL19913333 0.90 MYC (0.38) MYCALDH1A3GABRG2GABRB3GABRA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287451-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 MYC 1697/4885ALDH1A3 38/4885GABRG2 1265/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 MYC 1636/4885ALDH1A3 192/4885GABRG2 3357/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 MYC 1697/4885ALDH1A3 38/4885GABRG2 1265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.